| Year |
Citation |
Score |
| 2018 |
Vonderhaar E, Dwinell M, Roy IR, McAllister DM, Dwinell MB. 2543 High concentrations of CXCL12 decrease pancreatic adenocarcinoma growth Journal of Clinical and Translational Science. 2: 13-14. DOI: 10.1017/cts.2018.79 |
0.389 |
|
| 2017 |
Ziarek JJ, Kleist AB, London N, Raveh B, Montpas N, Bonneterre J, St-Onge G, DiCosmo-Ponticello CJ, Koplinski CA, Roy I, Stephens B, Thelen S, Veldkamp CT, Coffman FD, Cohen MC, et al. Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation. Science Signaling. 10. PMID 28325822 DOI: 10.1126/Scisignal.Aah5756 |
0.336 |
|
| 2017 |
Roy I, Boyle KA, Vonderhaar EP, Zimmerman NP, Gorse E, Mackinnon AC, Hwang RF, Franco-Barraza J, Cukierman E, Tsai S, Evans DB, Dwinell MB. Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 28092365 DOI: 10.1038/Labinvest.2016.146 |
0.564 |
|
| 2016 |
Roy I, Getschman AE, Volkman BF, Dwinell MB. Exploiting agonist biased signaling of chemokines to target cancer. Molecular Carcinogenesis. PMID 27648825 DOI: 10.1002/Mc.22571 |
0.483 |
|
| 2016 |
Roy I, Boyle KA, Mackinnon AC, Hwang RF, Tsai S, Evans DB, Dwinell MB. Abstract A21: Chemokine directed migration of activated stellate cells in pancreatic ductal adenocarcinoma Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-A21 |
0.578 |
|
| 2015 |
Roy I, McAllister DM, Gorse E, Dixon K, Piper CT, Zimmerman NP, Getschman AE, Tsai S, Engle DD, Evans DB, Volkman BF, Kalyanaraman B, Dwinell MB. Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling. Cancer Research. 75: 3529-42. PMID 26330165 DOI: 10.1158/0008-5472.Can-14-2645 |
0.488 |
|
| 2015 |
Zimmerman NP, Roy I, Hauser AD, Wilson JM, Williams CL, Dwinell MB. Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells. Molecular Carcinogenesis. 54: 203-15. PMID 24115212 DOI: 10.1002/Mc.22091 |
0.49 |
|
| 2015 |
Roy I, McAllister D, Gorse E, Dixon K, Cheng G, Getschman A, Engle D, Tsai S, Tuveson D, Evans D, Volkman B, Kalyanaraman B, Dwinell M. Abstract B55: Chemokine biased agonists regulate pancreatic cancer migration and metastasis through bioenergetic signaling Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-B55 |
0.47 |
|
| 2014 |
Flister MJ, Endres BT, Rudemiller N, Sarkis AB, Santarriaga S, Roy I, Lemke A, Geurts AM, Moreno C, Ran S, Tsaih SW, De Pons J, Carlson DF, Tan W, Fahrenkrug SC, et al. CXM: a new tool for mapping breast cancer risk in the tumor microenvironment. Cancer Research. 74: 6419-29. PMID 25172839 DOI: 10.1158/0008-5472.Can-13-3212 |
0.369 |
|
| 2014 |
Roy I, Evans DB, Dwinell MB. Chemokines and chemokine receptors: update on utility and challenges for the clinician. Surgery. 155: 961-73. PMID 24856117 DOI: 10.1016/J.Surg.2014.02.006 |
0.46 |
|
| 2014 |
Roy I, Zimmerman NP, Mackinnon AC, Tsai S, Evans DB, Dwinell MB. CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. Plos One. 9: e90400. PMID 24594697 DOI: 10.1371/Journal.Pone.0090400 |
0.562 |
|
| 2014 |
Roy I, Zimmerman NP, MacKinnon A, Tsai S, Evans DB, Dwinell MB. Tu1657 CXCL12 Suppresses Pancreatic Cancer by Regulating Tumor Cell Growth, Migration, and Metastatic Homing Gastroenterology. 146: S-811. DOI: 10.1016/S0016-5085(14)62933-4 |
0.513 |
|
| 2012 |
Roy I, Zimmerman NP, Tsai S, Evans DB, Dwinell MB. Abstract A74: CXCL12 and CXCR4 are reciprocally expressed in normal pancreatic ducts and pancreatic ductal adenocarcinoma respectively. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-A74 |
0.529 |
|
| 2012 |
Zimmerman N, Roy I, Wilson J, Dwinell M. Abstract 473: Elevated cAMP decreases migratory potential in pancreatic cancer cells Cancer Research. 72: 473-473. DOI: 10.1158/1538-7445.Am2012-473 |
0.506 |
|
| Show low-probability matches. |